Health experts at Oxford University Hospitals are urging members of the public to undergo testing for hepatitis B and hepatitis C ahead of World Hepatitis Day on Tuesday, July 28.

Medical professionals from the trust are highlighting the dangers of both viral infections, which frequently progress without any visible signs for extended periods. Should these conditions remain unaddressed, they may result in severe liver damage, cirrhosis and malignant growths in the liver.

Lizi Sims, who leads the hepatology community nursing service at the trust, explained that individuals carrying these infections frequently remain unaware of their condition since early stages typically produce no warning signals. She noted that the infection may remain inactive until patients present with advanced complications.

According to Ms Sims, screening procedures are straightforward, and identifying the infection promptly can substantially improve outcomes. She added that medication capable of managing hepatitis B is accessible, while a significant proportion of those with hepatitis C can achieve full recovery.

Worldwide data indicates approximately 287 million individuals carry either hepatitis B or C, with annual mortality exceeding 1.3 million.

Within Oxfordshire alone, nearly 400 patients are presently undergoing management for hepatitis B. figures from specialists covering the Thames Valley region show 187 individuals received care for hepatitis C during the 2025/26 period.

On Tuesday July 28, the trust’s hepatology community specialists will set up an advisory stall at the John Radcliffe Hospital on Level 2 between 8.30am and 4.30pm. The public and hospital employees will have the opportunity to obtain additional knowledge about hepatitis alongside guidance on available testing and therapeutic options.